We serve Chemical Name:5-Methyl-2-hex-2-enoic Acid CAS:41653-96-7 to global customers since 2007, Pls send inquiry to info@nbinno.com or visit www.nbinno.com our official website should you have any interests. This site is for information only.
Chemical Name:5-Methyl-2-hex-2-enoic Acid
CAS.NO:41653-96-7
Synonyms:5-methyl-hex-2-en-1-oic acid;trans-5-methylhex-2-enoic acid;5-methylhex-2-enoic acid;(E)-5-METHYL-HEX-2-ENOIC ACID;(E)-5-methyl-2-hexenoic acid;5-Methyl-2-hexenoic Acid
Molecular Formula:C7H12O2
Molecular Weight:128.16900
HS Code:2916190090
Physical and Chemical Properties:
Melting point:N/A
Boiling point:82ºC/1mmHg
Density:N/A
Index of Refraction:
PSA:37.30000
Exact Mass:128.08400
LogP:1.67330
Material Safety Information (Applicable for Hazard Chemicals)
RIDADR:
Packing Group:
Contact us for information like 5-methyl-hex-2-en-1-oic acid chemical properties,Structure,melting point,boiling point,density,molecular formula,molecular weight,5-Methyl-2-hexenoic Acid physical properties,toxicity information,customs codes,safety, risk, hazard and MSDS, CAS,cas number,5-methylhex-2-enoic acid Use and application,(E)-5-methyl-2-hexenoic acid technical grade,usp/ep/jp grade.
Related News: Though the program obtained priority review from FDA back in November, analysts expressed skepticism in July 2020 after it failed to prove superior to the companies’ other drug Lumizyme in improving respiratory function in a Phase III trial. 4-(oxan-4-yl)benzoic acid manufacturers Biogen’s Alzheimer’s drug, Aduhelm, generated $2 million in revenue in the first few weeks of its approval, the company said Thursday in releasing its second-quarter earnings along with an open letter about the controversial drug. (Z)-11-TETRADECEN-1-YL ACETATE suppliers In addition, the government has made a series of new commitments, including: 1,2,5-trihydroxyanthracene-9,10-dione vendor & factory Though the program obtained priority review from FDA back in November, analysts expressed skepticism in July 2020 after it failed to prove superior to the companies’ other drug Lumizyme in improving respiratory function in a Phase III trial.,Other innovative technology developments have made immobilizing enzymes on solid supports like glass, silicon, or any other polymer more efficient.
